Similar findings were reported by Su et al. (Su et al., 2015) in the case of BRAF-activated non-coding RNA (BANCR); although BANCR plays a tumor-suppressing role in other types of cancers, it was found to be overexpressed in RB and to affect prognosis, with a median of 20 months of OS recorded for patients with high expression of BANCR as compared to a median of >60 months for patients with low expression (p < 0.001). This evidence concerns the gene BANCR and cancer.